Polymyalgia Rheumatica Drugs Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Polymyalgia Rheumatica Drugs Market is segmented By Therapy (Therapy A, Therapy B, Therapy C, Therapy D), By Class (Class A, Class B, Class C, Class D....
Polymyalgia Rheumatica Drugs Market Size
Market Size in USD
CAGR13.9%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 13.9% |
| Market Concentration | Medium |
| Major Players | Sparrow Pharmaceuticals, Novartis Pharmaceuticals, Roche Chugai, Chugai Pharmaceutical, Genentech Inc. |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Polymyalgia Rheumatica Drugs Market Analysis
The polymyalgia rheumatica drugs market is estimated to be valued at USD 266 Mn in 2024 and is expected to reach USD 662 Mn by 2031, growing at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.
Market growth can be attributed to the increasing geriatric population worldwide who are at a higher risk of developing polymyalgia rheumatica and rising awareness among people about the disease.